Dogecoin Cash, Inc. Announces PrestoDoctor’s Expansion into Three New Markets
Dogecoin Cash (OTCQB: DOGP) announced the expansion of its subsidiary PrestoDoctor into three new states: Arizona, Massachusetts, and Virginia. The expansion brings PrestoDoctor's HIPAA-compliant medical cannabis telehealth services to markets with a combined population of over 23 million people.
The company's proprietary telemedicine platform, developed by CEO Kyle Powers, serves 18 states total and features secure video consultations, encrypted patient records, and digital delivery of recommendations. The expansion targets markets where over 1.2 million residents are registered medical marijuana patients, capitalizing on the nationwide trend of increased telehealth usage, which has grown 38-fold since 2020.
Dogecoin Cash (OTCQB: DOGP) ha annunciato l'espansione della sua controllata PrestoDoctor in tre nuovi stati: Arizona, Massachusetts e Virginia. Questa espansione porta i servizi telemedici per la cannabis medica conformi alla normativa HIPAA di PrestoDoctor in mercati con una popolazione complessiva superiore a 23 milioni di persone.
La piattaforma proprietaria di telemedicina dell'azienda, sviluppata dall'amministratore delegato Kyle Powers, opera in 18 stati in totale e offre consulenze video sicure, cartelle cliniche criptate e la consegna digitale delle raccomandazioni. L'espansione mira a mercati dove oltre 1,2 milioni di residenti sono pazienti registrati per la marijuana medica, sfruttando la tendenza nazionale all'aumento dell'uso della telemedicina, cresciuta 38 volte dal 2020.
Dogecoin Cash (OTCQB: DOGP) anunció la expansión de su subsidiaria PrestoDoctor a tres nuevos estados: Arizona, Massachusetts y Virginia. Esta expansión lleva los servicios de telemedicina para cannabis medicinal compatibles con HIPAA de PrestoDoctor a mercados con una población combinada de más de 23 millones de personas.
La plataforma de telemedicina propia de la compañía, desarrollada por el CEO Kyle Powers, atiende a 18 estados en total y ofrece consultas por video seguras, registros de pacientes encriptados y entrega digital de recomendaciones. La expansión se dirige a mercados donde más de 1.2 millones de residentes están registrados como pacientes de marihuana medicinal, aprovechando la tendencia nacional del aumento en el uso de telemedicina, que ha crecido 38 veces desde 2020.
Dogecoin Cash (OTCQB: DOGP)는 자회사 PrestoDoctor를 새로운 3개 주: 애리조나, 매사추세츠, 버지니아로 확장한다고 발표했습니다. 이번 확장을 통해 PrestoDoctor의 HIPAA 준수 의료용 대마 텔레헬스 서비스가 총 2300만 명이 넘는 인구를 보유한 시장에 제공됩니다.
CEO Kyle Powers가 개발한 회사 고유의 원격진료 플랫폼은 총 18개 주에서 운영되며, 안전한 화상 상담, 암호화된 환자 기록, 디지털 추천서 전달 기능을 갖추고 있습니다. 이번 확장은 120만 명 이상의 등록 의료용 마리화나 환자가 있는 시장을 대상으로 하며, 2020년 이후 38배 증가한 원격의료 사용 증가 추세를 활용합니다.
Dogecoin Cash (OTCQB : DOGP) a annoncé l'expansion de sa filiale PrestoDoctor dans trois nouveaux États : Arizona, Massachusetts et Virginie. Cette expansion permet aux services de télémédecine pour le cannabis médical conformes à la HIPAA de PrestoDoctor d'atteindre des marchés comptant une population combinée de plus de 23 millions de personnes.
La plateforme de télémédecine propriétaire de l'entreprise, développée par le PDG Kyle Powers, dessert au total 18 États et propose des consultations vidéo sécurisées, des dossiers patients cryptés et la livraison numérique des recommandations. L'expansion cible des marchés où plus de 1,2 million de résidents sont des patients enregistrés pour le cannabis médical, tirant parti de la tendance nationale à l'augmentation de l'utilisation de la télésanté, qui a été multipliée par 38 depuis 2020.
Dogecoin Cash (OTCQB: DOGP) gab die Erweiterung seiner Tochtergesellschaft PrestoDoctor in drei neue Bundesstaaten: Arizona, Massachusetts und Virginia bekannt. Die Expansion bringt PrestoDoctors HIPAA-konforme Telemedizin-Dienste für medizinisches Cannabis in Märkte mit einer gesamten Bevölkerung von über 23 Millionen Menschen.
Die firmeneigene Telemedizinplattform, entwickelt vom CEO Kyle Powers, ist insgesamt in 18 Bundesstaaten aktiv und bietet sichere Video-Konsultationen, verschlüsselte Patientenakten und digitale Übermittlung von Empfehlungen. Die Expansion zielt auf Märkte ab, in denen über 1,2 Millionen Einwohner als registrierte medizinische Marihuana-Patienten gelten und nutzt den landesweiten Trend zur verstärkten Nutzung von Telemedizin, die seit 2020 um das 38-Fache gewachsen ist.
- None.
- Operating in highly regulated medical cannabis market requiring strict compliance
- Faces competition from established telehealth providers
Arizona, Massachusetts, and Virginia
Mesquite, NV, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dogecoin Cash, Inc. (OTCQB: DOGP), a publicly traded company focused on telehealth services and blockchain-based innovation, today announced that its wholly owned subsidiary, PrestoDoctor,
(www.prestodoctor.com) has expanded operations into three additional U.S. states: Arizona, Massachusetts, and Virginia, offering access to secure, legally valid online consultations for medical cannabis evaluations. This expansion results in the availability of PrestoDoctor’s HIPAA-compliant medical cannabis telehealth services within jurisdictions encompassing a combined population exceeding 23 million individuals. According to publicly available data, more than 1.2 million residents across these three states have registered as medical marijuana patients since their respective programs began. Active participation continues in each market, with Arizona and Massachusetts maintaining sizable medical registries and Virginia offering certification under its medical cannabis laws.
The expansion also aligns with broader healthcare trends: nationwide telehealth usage has increased by a factor of 38 since 2020, reflecting a shift toward digital-first healthcare access.
“With each new state we enter, PrestoDoctor continues its commitment to responsible, compliant, and secure patient access,” said a spokesman for Dogecoin Cash, Inc. “This growth reflects our team’s disciplined approach to regulation and technology.”
PrestoDoctor currently operates in 18 states and remains focused on compliance with all applicable medical cannabis laws and telemedicine standards in the jurisdictions it serves.
Telehealth Platform Built for Compliance and Scale
PrestoDoctor operates a proprietary telemedicine platform developed in-house by Kyle Powers, Co-Founder and CEO. The software includes features for secure video consultations, encrypted patient records, real-time physician scheduling, and digital delivery of recommendations, designed specifically for medical cannabis telehealth.
Unlike third-party solutions, the system is custom-built to meet HIPAA privacy standards and to align with evolving state regulations.
About Kyle Powers, CEO
Kyle Powers is an experienced software developer with a background in building applications for regulated industries, including fintech and healthcare IT. Before co-founding PrestoDoctor in 2015, he worked with enterprise clients on electronic health records and secure payment systems. In 2018, Powers was named to the Forbes 30 Under 30 – Healthcare list, a third-party recognition highlighting young leaders in the industry.
He holds a Bachelor of Science in Computer Science from the University of Nebraska–Lincoln.
About PrestoDoctor
Founded in 2015 by Kyle Powers and Robert Tankson, PrestoDoctor is a licensed telehealth provider offering online consultations with physicians authorized to recommend medical cannabis. The company operates in multiple U.S. states, using a secure, HIPAA-compliant platform and a team of board-certified doctors
About Dogecoin Cash, Inc. (OTCQB: DOGP)
Dogecoin Cash, Inc. (OTCQB: DOGP) is a publicly traded company that owns and operates PrestoDoctor, a trusted leader in medical cannabis telemedicine. DOGP holds the first patented cannabis strain, Ecuadorian Sativa aka “CTA”, and a patented cannabis lozenge for treatment of hypertension. The company is actively engaged in leveraging emerging digital assets, decentralized finance (DeFi) solutions, and blockchain technology to enhance its offerings and create new market opportunities.
Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding future operations, financial performance, and expansion plans. These statements are based on current expectations and assumptions and are subject to various risks and uncertainties.
Actual results may differ materially from those expressed or implied in forward-looking statements due to a number of important factors, including risks disclosed in the Company’s filings with the Securities and Exchange Commission. These factors include, without limitation, general economic, industry, market, and regulatory conditions, as well as shifts in public policy.
Forward-looking statements reflect the Company’s views only as of the date of this release. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Investors are cautioned not to place undue reliance on these statements. A full discussion of risks and other factors that may affect the Company’s performance is available in its public filings and on its website.
Media Contact:
Dogecoin Cash, Inc.
Email: info@dogecoincash.com
Website: www.dogecoincash.com
FAQ
Which new states did PrestoDoctor (DOGP) expand into in August 2025?
How many states does PrestoDoctor operate in as of August 2025?
What is the total patient market size in PrestoDoctor's new states?
What features does PrestoDoctor's telehealth platform include?
Who developed PrestoDoctor's telehealth platform?
